View PDF
 |
| |
|
Cover |
| |
|
Commentary |
| |
| Figures
and Tables |
|
Figure 1 |
Location of Enhanced Perinatal Surveillance Project Sites, 1999–2001 |
|
Table 1 |
Number and percentage of pregnant women with HIV infection who gave birth to a live infant, by year of infant’s birth and selected characteristics of mother, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 2 |
Prenatal care of HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 3 |
Timing of HIV testing of HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 4 |
Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 5 |
Method of delivery for HIV-infected women, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 6 |
Substance use and toxicology screening of HIV-infected women during pregnancy, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 7 |
Screening of HIV-infected women during pregnancy, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 8 | Number and percentage of HIV-infected women with positive test results for selected conditions, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 9 |
Prenatal care of HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 10 |
Timing of HIV testing of HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 11 |
Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 1999–2001—24 areas conducting Enhanced
Perinatal Surveillance |
|
Table 12 |
Method of delivery for HIV-infected women, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 13 |
Substance use and toxicology screening of HIV-infected women during pregnancy, by race/ethnicity and year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 14 | Type of birth, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 15 |
Number and percentage of infants receiving prophylaxis against
Pneumocystis carinii pneumonia, by year of birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
|
Table 16 |
Number and percentage of infants infected with HIV through mother-to-child transmission, as of October 2003, by year of infant’s birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance |
| |
|
Technical
Notes |
